HOME >> BIOLOGY >> NEWS
Mouse Model Of Down Syndrome Offers Glimpse Into Role Of Specific Genes In TheDisorder

The human genome is comprised of 22 pairs of chromosomes, as well as two chromosomes that determine a person's gender. And researchers have known for decades that Down syndrome is associated with an extra copy of all or part of one of these: chromosome 21.

However, scientists have yet to identify the particular genes on this extra chromosome that cause the mental and physical abnormalities associated with the disorder. And this lack of knowledge has stymied drug development because drugs need targets, either the genes or the proteins they produce.

Now, however, in a recent issue of Proceedings of the National Academy of Science, researchers at UC San Francisco report that they have developed a mouse model that should enable them for the first time to delineate the role of specific genes in particular aspects of a Down syndrome-like disorder in mice. This model, says senior author Ting-Ting Huang, PhD, an assistant adjunct professor of pediatrics in the pediatric-medical genetics laboratory of Charles Epstein, MD, at UCSF should allow researchers to assess potential pharmacological agents and various forms of environmental enrichment, such as training, in these mice.

Ultimately, of course, the researchers hope such research would lead to the development of drugs to treat humans with Down syndrome, which causes mental retardation, major and minor physical abnormalities, often including heart disorders, and, in later life, Alzheimer's disease.

The new mouse model, called Ts1Cje, includes a partial third segment of mouse chromosome 16, the equivalent of a region on chromosome 21 in humans that is associated with Down syndrome.

It is not the first mouse model of Down syndrome--in fact, one of the previous standard models, known as "full trisomy 16," was also developed at UCSF--but it is the first to represent just a particularly small portion of the region of chromosome 16 that has strong parallels to some of the neurological disorders of the disease
'"/>

Contact: Jennifer O'Brien
jobrien@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
1-Jun-1998


Page: 1 2 3

Related biology news :

1. Half-million dollar landmark achieved for the Methuselah Mouse Prize
2. Mouse study shows NPAS3 and NPAS1 genes may be linked to psychosis
3. Mouse brain stem cells capable of converting into blood vessel cells
4. Mouse study yields clue to why liver is less prone to rejection, say Pitt researchers
5. Mouse embryonic germ cells and male gametes created in the lab
6. Mouse, stripped of a key gene, resists diabetes
7. Mouse model of schizophrenia could speed identification of new antipsychotic drugs
8. Mouse study identifies protective mechanism against alcohol-induced embryo toxicity
9. Mouse model offers new explanation for kidney disease and failure
10. Mouse study suggests mammoth evolutionary change
11. Mouse genetic model for spongiform brain diseases

Post Your Comments:
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... Biology (SDB) 72nd Annual Meeting in Cancun, Mexico ... to promote the entry of students, postdoctorates and ... the basic science community and to encourage the ... Annual Meeting. , Awards are given to poster/platform ...
(Date:5/16/2013)... MIT may someday eliminate the need for patients ... blood-sugar levels and inject themselves with insulin. , ... in the body and respond by secreting the ... of pancreatic islet cells, which are destroyed in ... of system could ensure that blood-sugar levels remain ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., a ... in epilepsy and related neurological disorders, is today reporting ... lead compound INS001 in patients with drug-resistant epilepsy.  The ... Device Trials (AED) Xll meeting by Dr. ... Chairman of Insero,s Scientific Advisory Board.  In this study, ...
(Date:5/17/2013)... IAC Industries wants to share with you the ... to set up and furnish a research lab knowing that ... a year’s time. How does a company make choices in ... What is efficient and cost-effective? , The solution was ... The planners at DisperSol determined that the concept of modular ...
(Date:5/16/2013)... In late 2012, Dr. Sarah Hart, of Palm ... China about Appearance Medicine . Although Dr. Hart regularly ... trip to lecture in China, and quite a different experience ... to 12 and 7 million people respectively. Interest in cosmetic ... point in time. As Dr. Hart passed through the Fuzhou ...
(Date:5/16/2013)... SAN DIEGO , May 16, 2013  The ... the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, ... will be held May 28-31 at the Hilton San ... finishing touches on this year,s conference and want to ... opportunity to attend," said Brandi Roberts ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4
Cached News: